Journey Strategic Wealth »

Larimar Therapeutics shares owned by Journey Strategic Wealth

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Journey Strategic Wealth from 13F filings

Historical chart of Journey Strategic Wealth investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Journey Strategic Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Journey Strategic Wealth

Quarter filed Position value Share count Share price at filing
2024-09-30 $231k 35k 6.55
2024-06-30 $256k 35k 7.25
2024-03-31 $268k 35k 7.59
2023-12-31 $160k 35k 4.55
2023-09-30 $139k 35k 3.95
2023-06-30 $110k 35k 3.13

More positions owned by Journey Strategic Wealth

Johnson & Johnson (JNJ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Pepsi (PEP)
Ishares Tr Esg Awr Msci Usa (ESGU)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Microsoft Corporation (MSFT)
Wisdomtree Tr Intl Qulty Div (IQDG)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Invesco Actively Managed Exc Total Return (GTO)

View all positions for Journey Strategic Wealth

Top funds holding Larimar Therapeutics

Deerfield Management Company
RA Capital Management
Henderson Group
Goldman Sachs Group
Blue Owl Capital Holdings
BlackRock
BlackRock
Vanguard Group
Verition Fund Management
Driehaus Capital Management
Woodline Partners
State Street Corporation
Geode Capital Management
Altium Capital Management
Fred Alger Management

View all funds holding Larimar Therapeutics